Orchard Therapeutics plc (ORTX): Price and Financial Metrics

Orchard Therapeutics plc (ORTX): $0.44

0.00 (-0.68%)

POWR Rating

Component Grades













ORTX Stock Price Chart Interactive Chart >

Price chart for ORTX

ORTX Price/Volume Stats

Current price $0.44 52-week high $1.55
Prev. close $0.44 52-week low $0.41
Day low $0.43 Volume 390,600
Day high $0.45 Avg. volume 588,248
50-day MA $0.46 Dividend yield N/A
200-day MA $0.57 Market Cap 55.11M

Orchard Therapeutics plc (ORTX) Company Bio

Orchard Therapeutics Plc is a biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of gene therapies. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). It operates through the United Kingdom and United States geographical segments. The company was founded in August 2018 and is headquartered in London, the United Kingdom.

ORTX Latest News Stream

Event/Time News Detail
Loading, please wait...

ORTX Latest Social Stream

Loading social stream, please wait...

View Full ORTX Social Stream

Latest ORTX News From Around the Web

Below are the latest news stories about Orchard Therapeutics plc that investors may wish to consider to help them evaluate ORTX as an investment opportunity.

Orchard Therapeutics: Cutting-Edge Science Beset With A Pioneer's Typical Hurdles

Orchard Therapeutics (ORTX), which I covered in multiple articles over the past year, is a leading gene therapy developer. In 2018, ORTX stuck a deal whereby, against a 20% stake and a position on its BoD, GlaxoSmithKline (GSK) sold it their entire gene therapy program. Orchard's non-GSK asset Strimvelis is...

Avisol Capital Partners on Seeking Alpha | NA NA, NA

Read More 'ORTX' Stories Here

ORTX Price Returns

1-mo -1.30%
3-mo -15.38%
6-mo -20.29%
1-year -66.92%
3-year -96.32%
5-year N/A
YTD -66.67%
2021 -69.44%
2020 -68.58%
2019 -12.59%
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8668 seconds.